Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $422 | $309 | $913 | $614 |
| - Cash | $9 | $28 | $33 | $139 |
| + Debt | $212 | $246 | $238 | $329 |
| Enterprise Value | $625 | $527 | $1,118 | $804 |
| Revenue | $40 | $67 | $23 | $9 |
| % Growth | -40.1% | 195.6% | 151% | – |
| Gross Profit | $6 | $35 | -$3 | -$4 |
| % Margin | 14.9% | 52.9% | -15.4% | -47.6% |
| EBITDA | -$53 | $17 | -$82 | -$80 |
| % Margin | -131.4% | 26.1% | -362.9% | -890.1% |
| Net Income | -$174 | -$60 | -$117 | -$92 |
| % Margin | -432.1% | -89% | -515.6% | -1,019.8% |
| EPS Diluted | -2.51 | -1.22 | -2.69 | -2.25 |
| % Growth | -105.7% | 54.6% | -19.6% | – |
| Operating Cash Flow | -$2 | -$67 | -$86 | -$84 |
| Capital Expenditures | $0 | -$26 | -$21 | -$16 |
| Free Cash Flow | -$2 | -$92 | -$107 | -$100 |